Fri, Aug 29, 2014, 1:20 AM EDT - U.S. Markets open in 8 hrs 10 mins

Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • bladerunner1717 bladerunner1717 Sep 9, 2013 1:02 AM Flag

    ARRY insider sales

    Insider Selling: Array BioPharma Director Unloads 577,286 Shares of Stock (ARRY)

    Posted by Stuart Ham on Sep 6th, 2013 // No Comments

    Array BioPharma logoArray BioPharma (NASDAQ:ARRY) Director Liam Ratcliffe sold 577,286 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $5.79, for a total transaction of $3,342,485.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

    Bladerunner

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The wall street cheat sheet really hyping this deal. They have the shares sold at 139,572. I agree it is no big deal. Ratliff likely needed some money, has stock options like crazy and holds a considerable quantity even after the sale. Probably needed to refurbish his elk hunting camp.

      One day ARRY is going to take off. Will follow SGEN, ISIS and hopefully RGEN.

      Sentiment: Strong Buy

    • I have a friend who has owned shares of ISIS for many years, just believing and waiting. Finally, the thing took off. Before hitting it heights (which it may test again soon given recent positive developments), I noticed lots of insider sales (MUCH more than here) and advised caution. I'm glad he didn't sell based on my concerns. The truth is that there are as many reasons for insiders to sell shares as there are insiders. Lots of these folks have much of what they worked for in company stock, and these people need to pay their bills and chase their dreams just like we do. Calm down. The transactions you cite are really relatively modest, and likely mean less to individual investors than you are implying.

    • The sale was by New Leaf Venture Partner's. This is an investment firm owned by Ratcliff (of the Array BOD) . The Form 4 has Ratclifs name at top but clearly states New Leaf as the seller.

      So it is an instituional sale, not an insider sale.

 
ARRY
3.87-0.14(-3.49%)Aug 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.